SB-245570

SB-245570 is a serotonin 5-HT 1B receptor antagonist which was under development for the treatment of major depressive disorder but was never marketed.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

SB-245570 is a serotonin 5-HT 1B receptor antagonist which was under development for the treatment of major depressive disorder but was never marketed. It was being developed by GlaxoSmithKline in the 1990s. A chemical synthesis for SB-245570 has been published. The drug reached the preclinical research stage of development prior to the discontinuation of its development.

See also

List of investigational antidepressants

Text derived from https://en.wikipedia.org/w/index.php?oldid=1328696146 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

3 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.